Product Safety Recalls

Product Recall Tracker

TACROLIMUS Recall D-1304-2022

Description: Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC 68462-534-35, b) 60 g tube, NDC 68462-534-65, c) 100 g tube, NDC 68462-534-94, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India.

TACROLIMUS Recall D-1304-2022 Information

Mandated?Voluntary: Firm initiated
Recall NumberD-1304-2022
Event ID90550
Original Package?1
Active SubstanceTACROLIMUS
DistributionNationwide in the USA
Quantity654,756 tubes
Recall ReasonDefective Container: Tube split from side seam
Drug ClassificationClass III
Drug Code Info20220810
Product NDC68462-534
Drug UPC0368462534946
Recall Initiation Date20220711
Report Date20220810
Classification Date20220804
Address750 Corporate Dr
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient IdentifierWM0HAQ4WNM
Drug Application NumberANDA210393
Structured Product Labeling (SPL ID)cc97f54d-975c-4807-92bd-3558c221dc05
Structured Product Labeling (SPL Set ID)c2d2e3a1-f346-4245-b445-6dd44e371180
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.